MedPath

Effects of Aprepitant on Satiation, Gastric Volume, Gastric Accommodation and Gastric Emptying

Phase 1
Completed
Conditions
Healthy
Interventions
Drug: Placebo
Registration Number
NCT02989467
Lead Sponsor
Mayo Clinic
Brief Summary

This research study is being done to compare the effects of Aprepitant and placebo on fasting gastric volume, accommodation volume, satiation (fullness) and gastric emptying.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
27
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
PlaceboPlaceboSubjects will receive one placebo tablet daily for 5 consecutive days.
AprepitantAprepitantSubjects will receive one tablet daily for 5 consecutive days. On Day 1 subjects will take a 125mg tablet, on Days 2-5, subjects will take an 80 mg tablet.
Primary Outcome Measures
NameTimeMethod
Fasting Gastric Volume as Measured by Single Photon Emission Computed Tomography (SPECT)Day 5, approximately 15 minutes after radioactive marker is administered

Subjects will arrive to the Clinical Research and Trials Unit (CRTU) fasting. A radioactive marker will be administered intravenously. After a 10-15 minute wait period a fasting scan will be acquired using a dual-head gamma camera.

Satiation Expressed as Volume to FullnessDay 4, approximately 30 minutes after liquid meal

Subjects will do a satiation/nutrient drink test, consuming Ensure at a relatively constant rate of 30 ml/min. Subjects will record their sensations every 5 minutes using a numerical scale from 0-5, with level 0 being no symptoms, level 3 corresponding to fullness sensation after a typical meal, and level 5 corresponding to the maximal tolerated volume (maximum or unbearable fullness/satiation). This measure is the volume consumed when the fullness sensation reaches level 3.

Gastric Emptying Half-Time of Solids as Measured by ScintigraphyDay 3, approximately 2 hours after radiolabeled meal is ingested

The time for half of the ingested solids to leave the stomach.

Accommodation Volume as Measured by SPECTDay 5, approximately 30 minutes after liquid meal

This variable is calculated as postprandial gastric volume minus fasting volume.

Postprandial Gastric Volume as Measured by SPECTDay 5, approximately 30 minutes after liquid meal

At the completion of the fasting scan, the subject will consume 300 ml of Ensure followed by a postprandial scan using a dual-head gamma camera.

Secondary Outcome Measures
NameTimeMethod
Solid Gastric Emptying: Proportion of Meal Emptied at 2 HoursDay 3, approximately 2 hours after radiolabeled meal is ingested

On Day 3, subjects will take part in a gastric emptying by scintigraphy test. Subjects will be given a scrambled egg breakfast with toast and a glass of milk. The eggs and milk contain a small amount of radioactive substance. At the completion of the meal, subjects will stand in front of a special camera and pictures were taken at specific intervals. This outcome measure is the proportion of the radiolabeled meal emptied at 2 hours.

Maximum Tolerated Volume on Satiation TestDay 4, approximately 30 minutes after liquid meal

On Day 4, subjects will do a satiation/nutrient drink test. Participants will record their sensations every 5 minutes using a numerical scale from 0-5, with level 0 being no symptoms, level 3 corresponding to fullness sensation after a typical meal, and level 5 corresponding to the maximal tolerated volume (maximum or unbearable fullness/satiation). This measure is the volume consumed when the fullness sensation reaches level 5.

Individual Symptom Scores (Nausea, Bloating, Fullness, Pain) on Satiation TestDay 4, approximately 30 minutes after liquid meal

Postprandial symptoms of nausea, bloating, fullness, and pain will be measured using 100 mm horizontal visual analog scales, with the words "none" and "worst ever" anchored at each end.

Aggregate Symptoms ScoreDay 4, approximately 1 hour after liquid meal

Postprandial symptoms of nausea, bloating, fullness, and pain will be measured using 100 mm horizontal visual analog scales, with the words "none" and "worst ever" anchored at each end. The aggregate symptoms score is calculated by adding the mean individual scores. The lowest possible score would be 0 (none) and the highest maximum score possible is 400 (worst ever).

Absolute postprandial gastric volumeDay 5, approximately 1 hour after radioactive marker is administered

This is the total postprandial gastric volume

Solid Gastric Emptying: Proportion of Meal Emptied at 4 HoursDay 3, approximately 4 hours after radiolabeled meal is ingested

On Day 3, subjects will take part in a gastric emptying by scintigraphy test. Subjects will be given a scrambled egg breakfast with toast and a glass of milk. The eggs and milk contain a small amount of radioactive substance. At the completion of the meal, subjects will stand in front of a special camera and pictures were taken at specific intervals. This outcome measure is the proportion of the radiolabeled meal emptied at 4 hours.

Gastric Volume RatioDay 5, approximately 1 hour after radioactive marker is administered

Postprandial/fasting gastric volume

Trial Locations

Locations (1)

Mayo Clinic in Rochester

🇺🇸

Rochester, Minnesota, United States

© Copyright 2025. All Rights Reserved by MedPath